This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mayer, A. Articles by Vaupel, P. Search for Related Content PubMed PubMed Citation Articles by Mayer, A. Articles by Vaupel, P.

Carbonic Anhydrase IX Expression and Tumor Oxygenation Status Do Not Correlate at the Microregional Level in Locally Advanced Cancers of the Uterine Cervix

Authors' Affiliations: ¹ Institute of Physiology and Pathophysiology, University of Mainz, Mainz, Germany and ² Department of Obstetrics and Gynecology, University of Leipzig, Leipzig, Germany

Requests for reprints: Arnulf Mayer, Institute of Physiology and Pathophysiology, University of Mainz, Duesbergweg 6, 55128 Mainz, Germany. Phone: 49-6131-392-5203; Fax: 49-6131-392-5774; E-mail: arnmayer{at}uni-mainz.de.

Purpose: Carbonic anhydrase IX (CA IX) can be induced by hypoxia in vitro and shows an immunohistochemical expression pattern that is predominantly found in perinecrotic tumor areas and correlates with exogenous markers of hypoxia, such as pimonidazole. CA IX might therefore serve as an endogenous marker of tumor hypoxia, although comparisons of CA IX immunostaining with direct oxygenation measurements using pO₂ microsensors have thus far yielded contradictory results.

Experimental Design: Because tumor heterogeneity may be among the factors responsible for the discrepancy between the two methods, CA IX expression in tissue samples originating from oxygen microelectrode tracks of locally advanced cervical cancers was assessed in this study. Seventy-seven biopsy specimens were analyzed immunohistochemically using an anti–CA IX rabbit polyclonal antibody and semiquantitative scoring.

Results: CA IX expression showed no correlation with the oxygenation variables median pO₂ and hypoxic fraction 2.5, 5, or 10. Cases with higher International Federation of Gynecology and Obstetrics stages (IIb-IVa) exhibited stronger expression of CA IX (P = 0.035) and CA IX expression tended to be more prevalent in node-positive patients (P = 0.051).

Conclusions: These data indicate that CA IX cannot be recommended as a substitute for oxygen microelectrode measurements. That the expression of CA IX does not correlate with the oxygenation status may be due to the degree to which other factors, such as nutrient (e.g., glucose) deficiency or the action of oncogenic mutations, can modulate the in vivo expression of this protein, rendering a strict association with tumor hypoxia too unreliable for clinical use.

This article has been cited by other articles:

				H. Yoo, G. S. Baia, J. S. Smith, M. W. McDermott, A. W. Bollen, S. R. VandenBerg, K. R. Lamborn, and A. Lal Expression of the Hypoxia Marker Carbonic Anhydrase 9 Is Associated with Anaplastic Phenotypes in Meningiomas Clin. Cancer Res., January 1, 2007; 13(1): 68 - 75. [Abstract] [Full Text] [PDF]

				C. Leo, L.-C. Horn, C. Rauscher, B. Hentschel, A. Liebmann, G. Hildebrandt, and M. Hockel Expression of Erythropoietin and Erythropoietin Receptor in Cervical Cancer and Relationship to Survival, Hypoxia, and Apoptosis Clin. Cancer Res., December 1, 2006; 12(23): 6894 - 6900. [Abstract] [Full Text] [PDF]

				S. Patiar and A. L Harris Role of hypoxia-inducible factor-1{alpha} as a cancer therapy target Endocr. Relat. Cancer, December 1, 2006; 13(Supplement_1): S61 - S75. [Abstract] [Full Text] [PDF]